Received Apr 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
autoimmune disease; This serious case was reported by a consumer via interactive digital media and described the occurrence of autoimmune disorder in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced autoimmune disorder (Verbatim: autoimmune disease) (serious criteria GSK medically significant). The outcome of the autoimmune disorder was not reported. It was unknown if the reporter considered the autoimmune disorder to be related to Shingles vaccine. The company considered the autoimmune disorder to be unrelated to Shingles vaccine. Additional Information: GSK Receipt date: 23-APR-2026 This case was reported by a patient via interactive digital media. The patient got an autoimmune disease afterwards. The reporter stated that there was a big warning on advertising ads. The batch number was not provided, and we are unable to contact the reporter.; Sender's Comments: A case of Autoimmune disorder, on an unknown time after vaccination with unknown dose of Shingles vaccine, in a patient. Based on the available information a possible causality that the event was caused by GSK vaccine product cannot be ascertained. Consent for further follow up has not been received.